Welcome to LookChem.com Sign In|Join Free

CAS

  • or

26892-90-0

Post Buying Request

26892-90-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

26892-90-0 Usage

General Description

4-Hydroxyquinoline-3-carboxylic acid ethyl ester is a chemical compound with a molecular formula of C12H11NO3. It is commonly used in the pharmaceutical industry as a building block for the synthesis of various drugs and pharmaceuticals. 4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER possesses antimicrobial properties and has been studied for its potential use as an antibacterial and antifungal agent. Additionally, it has also been investigated for its potential anti-inflammatory and antioxidant properties. 4-Hydroxyquinoline-3-carboxylic acid ethyl ester is a versatile chemical with potential applications in various fields, including medicine and material science.

Check Digit Verification of cas no

The CAS Registry Mumber 26892-90-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,8,9 and 2 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 26892-90:
(7*2)+(6*6)+(5*8)+(4*9)+(3*2)+(2*9)+(1*0)=150
150 % 10 = 0
So 26892-90-0 is a valid CAS Registry Number.
InChI:InChI=1/C12H11NO3/c1-2-16-12(15)9-7-13-10-6-4-3-5-8(10)11(9)14/h3-7H,2H2,1H3,(H,13,14)

26892-90-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (BBO000183)  4-Hydroxyquinoline-3-carboxylic acid ethyl ester  AldrichCPR

  • 26892-90-0

  • BBO000183-1G

  • 966.42CNY

  • Detail

26892-90-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER

1.2 Other means of identification

Product number -
Other names ETHYL 4-HYDROXYQUINOLINE-3-CARBOXYLATE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:26892-90-0 SDS

26892-90-0Relevant articles and documents

Syntheses and photochromic behavior of biquinolinium salts

Nanasawa,Tomoda,Hirai

, p. 163 - 168 (2000)

Three isomers of N,N′-dibenzy-biquinolinium dibromide were synthesized and their photoinduced coloration properties were investigated in the thin poly(N-vinylpyrrolidone) films. Upon photo-irradiation, the colorless film of 4,4′-biquinolinium salt became

-

Gould,Jacobs

, p. 2890,2893 (1939)

-

Synthesis method and device of 4 -hydroxyquinoline -3 - formic acid

-

, (2021/09/21)

The invention relates to the technical field of medicine preparation, and particularly discloses a synthesis method and device of 4 -hydroxyquinoline -3 - formic acid, wherein o-nitrobenzoic acid and a monoethyl propionate potassium salt are condensed to obtain 3 - (2 - nitrophenyl) -3 - oxopropanoate. The ethyl powder is reacted with 3 - (2 - nitrophenyl) -3 - oxopropanoate to obtain 3 - (2 - aminophenyl) -3 - oxopropanoate. 3 - (2 - Aminophenyl) -3 - oxopropanoate was reacted with DMF-DMA and DMF via a closed loop to give 4 -hydroxyquinoline -3 - ethyl ester. The 4 -hydroxyquinoline -3 - formate was hydrolyzed under basic conditions to give 4 -hydroxyquinoline -3 - formic acid. 4 -hydroxyquinoline -3 - formic acid has the advantages of low cost, short reaction time and simple post-treatment in the synthesis process.

METHODS OF TREATMENT FOR CYSTIC FIBROSIS

-

, (2020/12/11)

This application describes methods of treating cystic fibrosis comprising administering Compound I:, a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising any of the foregoing.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 26892-90-0